Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AML2003: Standard vs Intensified Therapy in Adult AML
NCT00180102Phase 4Completed
- Sponsor
- Technische Universität Dresden
- Start
- Dec 2003
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of mitoxantrone, amsacrine in acute myeloid leukemia (AML), sponsored by Technische Universität Dresden. Started Dec 2003; status: completed.
02
Drugs
mitoxantroneamsacrine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00180102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180102.